A transcriptional switch governs fibroblast activation in heart disease

Michael Alexanian(Gladstone Institutes), Deepak Srivastava(Gladstone Institutes), Pawel F. Przytycki(Gladstone Institutes), Ana Catarina Silva(Universidade do Porto), Qiming Duan(Shanghai University), Franco Felix(Gladstone Institutes), Joshua G. Travers(University of Colorado Anschutz Medical Campus), Rudi Micheletti(University of Lausanne), Rajan Jain(Penn Center for AIDS Research), Arun Padmanabhan(Gladstone Institutes), Sanjeev S. Ranade(Discovery Institute), Casey A. Gifford(Stanford Health Care), Ricardo Linares-Saldana(California Institute for Regenerative Medicine), Bárbara González‐Terán(Gladstone Institutes), Clara Youngna Lee(Gladstone Institutes), Saptarsi M. Haldar(Amgen (United States)), Yu Huang(Gladstone Institutes), Timothy A. McKinsey(University of Colorado Anschutz Medical Campus), Angelo Pelonero(Gladstone Institutes), Nandhini Sadagopan(Gladstone Institutes), Gaia Andreoletti(Directorate-General for Interpretation), Li Li(University of Pennsylvania), Michael G. Rosenfeld(Howard Hughes Medical Institute), Lin Ye(Beijing Institute of Technology), Katherine S. Pollard(QB3)
Nature
June 23, 2021
Cited by 227


Related Papers